Daiichi Sankyo and Merck report phase 2 trial results for lung cancer drug
HCA Holdings Inc. stock has reached an all-time high, hitting 417.39 USD, with InvestingPro data showing the company maintains a "GREAT" overall financial health score of 3.25 out of 5. This milestone reflects a positive trajectory for the healthcare services company, which has seen a 1-year change of 7.42%. The company’s performance has been particularly impressive, with a 37.7% year-to-date return and consistent dividend growth of 9.1%. Management has been actively buying back shares, and 14 analysts have recently revised their earnings estimates upward. According to InvestingPro analysis, the stock currently appears slightly undervalued, with additional insights available in the comprehensive Pro Research Report. As HCA continues to navigate the evolving healthcare landscape, its stock performance remains a focal point for stakeholders and market analysts alike, with the company maintaining strong fundamentals including a 40.9% gross profit margin and $14.5 billion in EBITDA over the last twelve months.
In other recent news, HCA Healthcare has reported strong financial results for the second quarter of 2025. The company exceeded earnings and revenue forecasts, posting earnings per share of $6.84, which was higher than the expected $6.27, and generating revenue of $18.61 billion, surpassing the projected $18.49 billion. Following these results, Bernstein raised its price target for HCA Healthcare from $404 to $417, while maintaining a Market Perform rating. Despite the financial outperformance, Bernstein noted a slowdown in patient volumes during the quarter.
In contrast, Wolfe Research downgraded HCA Healthcare from Outperform to Peerperform, citing concerns about potential long-term payer mix pressures. Wolfe Research highlighted possible Exchange pressure in 2026 and Provider Tax pressure in 2028 and beyond as reasons for the downgrade. These developments present a mixed outlook for HCA Healthcare, with varying perspectives from different analyst firms.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.